BACKGROUND AND OBJECTIVES: Limited data exist on severe acute respiratory syndrome coronavirus 2 in children. We described infection rates and symptom profiles among pediatric household contacts of individuals with coronavirus disease 2019. METHODS: We enrolled individuals with coronavirus disease 2019 and their household contacts, assessed daily symptoms prospectively for 14 days, and obtained specimens for severe acute respiratory syndrome coronavirus 2 real-time reverse transcription polymerase chain reaction and serology testing. Among pediatric contacts (<18 years), we described transmission, assessed the risk factors for infection, and calculated symptom positive and negative predictive values. We compared secondary infection rates and symptoms between pediatric and adult contacts using generalized estimating equations. RESULTS: Among 58 households, 188 contacts were enrolled (120 adults; 68 children). Secondary infection rates for adults (30%) and children (28%) were similar. Among households with potential for transmission from children, child-to-adult transmission may have occurred in 2 of 10 (20%), and child-to-child transmission may have occurred in 1 of 6 (17%). Pediatric case patients most commonly reported headache (79%), sore throat (68%), and rhinorrhea (68%); symptoms had low positive predictive values, except measured fever (100%; 95% confidence interval [CI]: 44% to 100%). Compared with symptomatic adults, children were less likely to report cough (odds ratio [OR]: 0.15; 95% CI: 0.04 to 0.57), loss of taste (OR: 0.21; 95% CI: 0.06 to 0.74), and loss of smell (OR: 0.29; 95% CI: 0.09 to 0.96) and more likely to report sore throat (OR: 3.4; 95% CI: 1.04 to 11.18). CONCLUSIONS: Children and adults had similar secondary infection rates, but children generally had less frequent and severe symptoms. In two states early in the pandemic, we observed possible transmission from children in approximately one-fifth of households with potential to observe such transmission patterns.
BACKGROUND AND OBJECTIVES: Limited data exist on severe acute respiratory syndrome coronavirus 2 in children. We described infection rates and symptom profiles among pediatric household contacts of individuals with coronavirus disease 2019. METHODS: We enrolled individuals with coronavirus disease 2019 and their household contacts, assessed daily symptoms prospectively for 14 days, and obtained specimens for severe acute respiratory syndrome coronavirus 2 real-time reverse transcription polymerase chain reaction and serology testing. Among pediatric contacts (<18 years), we described transmission, assessed the risk factors for infection, and calculated symptom positive and negative predictive values. We compared secondary infection rates and symptoms between pediatric and adult contacts using generalized estimating equations. RESULTS: Among 58 households, 188 contacts were enrolled (120 adults; 68 children). Secondary infection rates for adults (30%) and children (28%) were similar. Among households with potential for transmission from children, child-to-adult transmission may have occurred in 2 of 10 (20%), and child-to-child transmission may have occurred in 1 of 6 (17%). Pediatric case patients most commonly reported headache (79%), sore throat (68%), and rhinorrhea (68%); symptoms had low positive predictive values, except measured fever (100%; 95% confidence interval [CI]: 44% to 100%). Compared with symptomatic adults, children were less likely to report cough (odds ratio [OR]: 0.15; 95% CI: 0.04 to 0.57), loss of taste (OR: 0.21; 95% CI: 0.06 to 0.74), and loss of smell (OR: 0.29; 95% CI: 0.09 to 0.96) and more likely to report sore throat (OR: 3.4; 95% CI: 1.04 to 11.18). CONCLUSIONS:Children and adults had similar secondary infection rates, but children generally had less frequent and severe symptoms. In two states early in the pandemic, we observed possible transmission from children in approximately one-fifth of households with potential to observe such transmission patterns.
Authors: Laura Ford; Melissa J Whaley; Melisa M Shah; Phillip P Salvatore; Hannah E Segaloff; Augustina Delaney; Dustin W Currie; Lauren Boyle-Estheimer; Michelle O'Hegarty; Clint N Morgan; Jennifer Meece; Lynn Ivacic; Natalie J Thornburg; Azaibi Tamin; Jennifer L Harcourt; Jennifer M Folster; Magdalena Medrzycki; Shilpi Jain; Phili Wong; Kimberly Goffard; Douglas Gieryn; Juliana Kahrs; Kimberly Langolf; Tara Zochert; Jacqueline E Tate; Christopher H Hsu; Hannah L Kirking Journal: J Pediatric Infect Dis Soc Date: 2021-12-31 Impact factor: 3.164
Authors: Mentor Ali Ber Lucien; Katilla Pierre; Gladzdin Jean-Denis; Jonas Rigodon; Caitlin M Worrell; Alexia Couture; Aspen Flynn; Mauricio Cerpa Calderon; Luis Felipe Codina; Andrea S Vicari; Samson Marseille; Koama T Jean Baptiste; Bernadette Fouche; Gerard Joseph; Ito Journel; Kenold Rendel; Yoran Grant-Greene; Nadia P Jean-Charles; Donald Lafontant; Senou Amouzou; Wilnique Pierre; Marie Greta Roy Clement; Stanley Juin; Jacques Boncy; Patrick Dely Journal: PLoS One Date: 2022-09-21 Impact factor: 3.752
Authors: Sareesh Naduvil Narayanan; Pooja Shivappa; Sreeshma Padiyath; Anand Bhaskar; Yan Wa Li; Tarig Hakim Merghani Journal: Front Public Health Date: 2022-06-06
Authors: Huong Q McLean; Carlos G Grijalva; Kayla E Hanson; Yuwei Zhu; Jessica E Deyoe; Jennifer K Meece; Natasha B Halasa; James D Chappell; Alexandra M Mellis; Carrie Reed; Edward A Belongia; H Keipp Talbot; Melissa A Rolfes Journal: Pediatrics Date: 2022-03-01 Impact factor: 9.703
Authors: Shari Krishnaratne; Hannah Littlecott; Kerstin Sell; Jacob Burns; Julia E Rabe; Jan M Stratil; Tim Litwin; Clemens Kreutz; Michaela Coenen; Karin Geffert; Anna Helen Boger; Ani Movsisyan; Suzie Kratzer; Carmen Klinger; Katharina Wabnitz; Brigitte Strahwald; Ben Verboom; Eva Rehfuess; Renke L Biallas; Caroline Jung-Sievers; Stephan Voss; Lisa M Pfadenhauer Journal: Cochrane Database Syst Rev Date: 2022-01-17
Authors: George J Delinasios; Paraskevi C Fragkou; Athina M Gkirmpa; George Tsangaris; Robert M Hoffman; Athanasios K Anagnostopoulos Journal: In Vivo Date: 2021 Mar-Apr Impact factor: 2.155
Authors: Marco Farronato; Carolina Dolci; Elisa Boccalari; Sara Izadi; Luis Hernan Salvatierra Rios; Maurizio Festa; Valentina Panetta; Danila De Vito; Gianluca Martino Tartaglia Journal: Int J Environ Res Public Health Date: 2021-02-04 Impact factor: 3.390
Authors: Jennifer Weidhaas; Zachary T Aanderud; D Keith Roper; James VanDerslice; Erica Brown Gaddis; Jeff Ostermiller; Ken Hoffman; Rubayat Jamal; Phillip Heck; Yue Zhang; Kevin Torgersen; Jacob Vander Laan; Nathan LaCross Journal: Sci Total Environ Date: 2021-02-12 Impact factor: 7.963